“3:44p ET 4/13/2022 - Benzinga
Why Biofrontera Stock Is Surging Today
Biofrontera Inc (NASDAQ: BFRI) shares are trading significantly higher Wednesday after the company announced it received U.S. Food and Drug Administration approval for its cGMP laboratory in Germany.
The FDA has approved Biofrontera's German laboratory as a contract lab for batch control and stability testing of Ameluz. This recognition enables significant improvements in product manufacturing efficiency, quality control and reliability of supply.
The clearance will allow part of the necessary testing of production batches to be performed in the company's Germany-based facility, thereby reducing dependence on third-party suppliers and the risk of production downtime and product delays.
Biofrontera is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions.
BFRI 52-Week Range: $2.20 - $14.63
According to data from Benzinga Pro, the stock was up 42.3% at $5.27 at time of publication.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
Since 4/13 - has closed six times below the lower bollinger band on the 3 month chart without closing above the upper bollinger band, earnings yoy expected up 30%, 10 million shares traded the last 5 days, is Armistice capital done selling ? The chart is overdue for a major increase, let’s have some sort of product communication before open that energizes this shareprice. 18.95 million O/S, would be a missed chart opportunity imo if nothing is promoted. BFRI was at 5.27 a share based on that news, so factoring in interest rate increases as priced in already why is this stock at an all time low, nothing else changed other than reporting the best first half revenue ever recorded. BFRI is 75% less valuable today than 3 months ago based on what metric.
my posts are always theory and not financial advice
